Omicron variant jab could be ready in 100 days: Pfizer

Pfizer is working on an updated jab in response to the Omicron variant that could be ready in 100 days, according to the head of American multinational pharmaceutical giant, who said that people......

US gives full approval to Pfizer Covid vaccine

The United States health regulator on Monday gave full approval to Pfizer-BioNTech's COVID-19 vaccine, a key milestone for public health that can instill further confidence in consumers and also......

US: First batch of COVID-19 vaccine roll out of Pfizer plant

United States pharmaceutical giant Pfizer has begun shipping the first batches of its long-awaited and newly-authorised coronavirus vaccine out of a Michigan warehouse, setting in motion the......

US authorizes Pfizer's COVID vaccine for emergency use

The United States Food and Drug Administration authorised Pfizer's Covid-19 vaccine for emergency use for the prevention of coronavirus disease in individuals 16 years of age and older. IMAGE: A......

Ranbaxy files suit against Pfizer

Leading Indian drug firm Ranbaxy has launched court battles in Britain and the US against the American pharmaceutical giant Pfizer for the rights to produce the cholesterol drug atorvastatin at a......

Viagra: HC relief for Pfizer

A medicine firm selling male potency drug has been restrained by the Delhi high court from using the term 'Indian Viagra' in its advertisements after the US pharmaceutical major Pfizer complained......

Cipla gets relief in patent battle with Pfizer

In what could mean a major setback for Pfizer, the patent office has again ruled in favour of Cipla, reinstating its earlier decision to revoke the American company’s patent for cancer drug......

Major blow to Ranbaxy's American dream

Less than three months after roaring into us market with generic for cholesterol-reducing Lipitor, Dept of Justice files for permanent injunction against Ranbaxy.Less than three months after......